HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44

Journal of Clinical Investigation

Volumn 122, Issue 12, 2012, Pages 4685-4697

  Frleta, Davor ^a   Ochoa, Carolyn E ^a   Kramer, Holger B ^b   Khan, Shaukat Ali ^a   Stacey, Andrea R ^b   Borrow, Persephone ^b   Kessler, Benedikt M ^b   Haynes, Barton F ^c   Bhardwaj, Nina ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

APOPTOTIC MICROPARTICLE; ARTICLE; CELL ADHESION; CELL DEATH; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MEMBRANE MICROPARTICLE; MONOCYTE; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

ANTIGENS, CD44; APOPTOSIS; CELL-DERIVED MICROPARTICLES; DENDRITIC CELLS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; TOLL-LIKE RECEPTORS; VIREMIA;

EID: 84870484583     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI64439     Document Type: Article

References (56)

1. Altfeld M, Fadda L, Frleta D, Bhardwaj N. DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol. 2011;11(3):176-186.
2. Goonetilleke N, et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med. 2009;206(6):1253-1272.
3. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol. 2010;10(1):11-23.
4. Sabado RL, et al. Evidence of dysregulation of dendritic cells in primary HIV infection. Blood. 2010; 116(19):3839-3852.
5. Tomaras GD, et al. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J Virol. 2008;82(24):12449-12463.
6. Fiebig EW, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. Aids. 2003;17(13):1871-1879. (Pubitemid 37070272)
7. Stacey AR, et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol. 2009; 83(8):3719-3733.
8. Turnbull EL, et al. Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection. J Immunol. 2009;182(11):7131-7145.
9. Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell. 2001; 106(3):263-266. (Pubitemid 32772609)
10. Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 2001;106(3):259-262.
11. Ferlazzo G, Munz C. NK cell compartments and their activation by dendritic cells. J Immunol. 2004; 172(3):1333-1339. (Pubitemid 38116773)
12. Ferlazzo G, et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A. 2004;101(47):16606-16611. (Pubitemid 39557760)
13. Donaghy H, Gazzard B, Gotch F, Patterson S. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood. 2003;101(11):4505-4511. (Pubitemid 36857821)
14. Brenchley JM, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004; 200(6):749-759. (Pubitemid 39299461)
15. Gasper-Smith N, et al. Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design. J Virol. 2008;82(15):7700-7710. (Pubitemid 352031235)
16. Finkel TH, et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med. 1995;1(2):129-134.
17. Richard J, Sindhu S, Pham TN, Belzile JP, Cohen EA. HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood. 2010;115(7):1354-1363.
18. Doitsh G, et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell. 2010;143(5):789-801.
19. Mailliard RB, et al. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol. 2003;171(5):2366-2373. (Pubitemid 37025543)
20. Alter G, et al. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol. 2009;83(13):6798-6805.
21. Hoffmann PR, et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol. 2005;174(3):1393-1404.
22. Skoberne M, et al. The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic- cell immunostimulatory function. Blood. 2006;108(3):947-955. (Pubitemid 44154630)
23. Bratton DL, Henson PM. Apoptotic cell recognition: will the real phosphatidylserine receptor(s) please stand up? Curr Biol. 2008;18(2):R76-R79.
24. Fanger NA, Wardwell K, Shen L, Tedder TF, Guyre PM. Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. J Immunol. 1996;157(2):541-548. (Pubitemid 26231354)
25. Moffat FL, et al. Involvement of CD44 and the cytoskeletal linker protein ankyrin in human neutrophil bacterial phagocytosis. J Cell Physiol. 1996;168(3):638-647.
26. Nauta AJ, et al. Opsonization with C1q and man-nose-binding lectin targets apoptotic cells to dendritic cells. J Immunol. 2004;173(5):3044-3050. (Pubitemid 39142010)
27. Skoberne M, Beignon AS, Larsson M, Bhardwaj N. Apoptotic cells at the crossroads of tolerance and immunity. Curr Top Microbiol Immunol. 2005; 289:259-292. (Pubitemid 40283467)
28. Vivers S, Dransfield I, Hart SP. Role of macrophage CD44 in the disposal of inflammatory cell corpses. Clin Sci (Lond). 2002;103(5):441-449. (Pubitemid 35305627)
29. Kerksiek KM, Niedergang F, Chavrier P, Busch DH, Brocker T. Selective Rac1 inhibition in dendritic cells diminishes apoptotic cell uptake and cross-presentation in vivo. Blood. 2005;105(2):742-749. (Pubitemid 40070761)
30. Niedergang F, Chavrier P. Regulation of phagocytosis by Rho GTPases. Curr Top Microbiol Immunol. 2005;291:43-60. (Pubitemid 40674910)
31. Beignon AS, et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor- viral RNA interactions. J Clin Invest. 2005; 115(11):3265-3275.
32. Fonteneau JF, et al. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol. 2004;78(10):5223-5232.
33. Lepelley A, et al. Innate sensing of HIV-infected cells. PLoS Pathog. 2011;7(2):e1001284.
34. Boggiano C, Manel N, Littman DR. Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN. J Virol. 2007;81(5):2519-2523.
35. Lambert AA, Gilbert C, Richard M, Beaulieu AD, Tremblay MJ. The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood. 2008;112(4):1299-1307.
36. Goldstone DC, et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature. 2011;480(7377):379-382.
37. Lahouassa H, et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol. 2012;13(3):223-228.
38. Laguette N, et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature. 2011;474(7353):654-657.
39. Manel N, Hogstad B, Wang Y, Levy DE, Unutmaz D, Littman DR. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature. 2010;467(7312):214-217.
40. Flaumenhaft R, Mairuhu AT, Italiano JE. Platelet-and megakaryocyte- derived microparticles. Semin Thromb Hemost. 2010;36(8):881-887.
41. Italiano JE Jr, Mairuhu AT, Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol. 2010;17(6):578-584.
42. Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010; 50(suppl 3):S85-S95.
43. Granich R, et al. Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res. 2011;9(6):446-469.
44. Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells. 1991;3(9):347-350.
45. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol. 1993;54:271-335. (Pubitemid 23289255)
46. Vachon E, et al. CD44 is a phagocytic receptor. Blood. 2006;107(10):4149-4158. (Pubitemid 43726826)
47. Weiss JM, et al. Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J Exp Med. 2001;194(9):1219-1229. (Pubitemid 33055041)
48. Muto J, Yamasaki K, Taylor KR, Gallo RL. Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. Mol Immunol. 2009;47(2-3):449-456.
49. Hart SP, Dougherty GJ, Haslett C, Dransfield I. CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages. J Immunol. 1997;159(2):919-925. (Pubitemid 127484246)
50. Vachon E, et al. CD44-mediated phagocytosis induces inside-out activation of complement receptor-3 in murine macrophages. Blood. 2007; 110(13):4492-4502. (Pubitemid 351377816)
51. Schmidt J, Klempp C, Buchler MW, Marten A. Release of iC3b from apoptotic tumor cells induces tolerance by binding to immature dendritic cells in vitro and in vivo. Cancer Immunol Immunother. 2006;55(1):31-38. (Pubitemid 41783290)
52. Kawana H, et al. CD44 suppresses TLR-mediated inflammation. J Immunol. 2008;180(6):4235-4245.
53. Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res. 1997;71:241-319. (Pubitemid 27197761)
54. Nchinda G, Amadu D, Trumpfheller C, Mizenina O, Uberla K, Steinman RM. Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells. Proc Natl Acad Sci U S A. 2010;107(9):4281-4286.
55. Palucka K, Banchereau J, Mellman I. Designing vaccines based on biology of human dendritic cell subsets. Immunity. 2010;33(4):464-478.
56. Spetz AL, et al. Induction of HIV-1-specific immunity after vaccination with apoptotic HIV-1/murine leukemia virus-infected cells. J Immunol. 2002; 169(10):5771-5779.